BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the selection of ...
Dr Maryam Ahmed Almustapha, an Abuja-based specialist, who has highlighted the alarming consequences of beating and physical abuse on pregnant women.
Insight Molecular Diagnostics Inc., (NASDAQ: IMDX) shares enjoyed strong gains at first Monday, on providing a year-end business update regarding its commercial progress, its GraftAssureDx™ test kit ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first ...
OHSU radiation oncologist presents promising study findings, launches a third, Medicare-backed study Nima Nabavizadeh, M.D., ...
GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
The false negative rates do not appear out of line with the test's sensitivity figures, but issues have been raised with its workflow and the firm's marketing strategy.
In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback